NCT07372196Recruiting
Left Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After Myectomy
Source: ClinicalTrials.gov · Last updated 28 Jan 2026
Brief summary (registry, in English)
Pilot interventional randomized clinical trial to study the efficacy of left bundle branch pacing in patients with hypertrophic cardiomyopathy after myectomy for the prevention of progression of heart failure, prevent the occurrence of life-threatening rhythm disturbances and promote reverse remodeling of the LV. The aim of the study is to evaluate the comparative efficacy and safety of implantation of a cardioverter-defibrillator with left bundle branch block pacing and a dual-chamber cardioverter-defibrillator in patients with HCM and complete left bundle branch block after myectomy at high risk of SCD. Objectives of the study: 1. To analyze the safety of ICD implantation procedures with LBBB pacing in patients with HCM and LBBB after myectomy at high risk of SCD; 2. To develop a technique for LBBB lead implantation in patients with HCM and LBBB after myectomy; 3. To conduct a comparative analysis of QRS complex duration data based on ECG data before and after surgery, LV activation time, and pacing threshold based on postoperative programming data; 4. To conduct a comparative analysis of the functional class of CHF, NT-proBNP, the presence/absence of interventricular and intraventricular dyssynchrony, the degree of diastolic dysfunction, LVEF, and LV EDV based on echocardiography data before and 12 months after surgery; 5. Conduct a comparative analysis of QRS complex duration data based on ECG data, LV activation time, pacing threshold, the presence of recorded episodes of AF, VT, VF, antitachycardia and shock therapy according to programming data at 3, 6, and 12 months after surgery; 6. Assess quality of life before and 12 months after surgery using the KCCQ-12 questionnaire; 30 patients (15 patients in each group) will be randomly separated into 2 groups. All participants go through ICD programming at 3, 6, and 12 months after myectomy, assessment of left ventricular remodeling based on ECG and echocardiography, NT-proBNP, assessment of quality of life before surgery and 12 months after surgery.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 1 Jan 2026
- Start date
- 14 Nov 2025
- Primary completion date
- 1 May 2027
- Lead sponsor
- Meshalkin Research Institute of Pathology of Circulation
- Diseases
- Heart failure, Hypertrophic cardiomyopathy
- NCT number
- NCT07372196
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 14 Nov 2025 to the primary completion date, 1 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of AMI less than three months prior to study inclusion;
Other illness
- Heart transplantation or implantation of an LVAD is planned within the next 6 months;
- Acute renal and hepatic failure;
- Acute infectious diseases;
- Presence of mental illness;
- Presence of other illnesses for which life expectancy is less than one year;
Other
- Absence of QRS complex morphology consistent with LBBB in LBBB with a positive QRS complex less than 130 ms;
- Presence of baseline complete RBBB;
- Patients with intermediate or low risk of SCD;
- Patient refusal to participate in the study at any stage;
Who the study is looking for
- Men and women aged 18 years and older;
- Patients with post-myectomy HCM who develop LBBB with a QRS complex greater than 130 ms and a high risk of SCD (HCM Risk-SCD ≥ 6%);
- Signed informed consent to participate in the study;
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Meshalkin Scientific Research Center of the Ministry of Health of Russia Coordinator of this site? Confirm its status | Novosibirsk | Russia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.